Synopsys CEO Sells $116,070 in Stock (SNPS)

Share on StockTwits

Synopsys (NASDAQ:SNPS) CEO Chi-Foon Chan sold 3,000 shares of Synopsys stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $38.69, for a total value of $116,070.00. Following the completion of the transaction, the chief executive officer now directly owns 193,899 shares in the company, valued at approximately $7,501,952. The sale was disclosed in a document filed with the SEC, which is available at this link.

Synopsys (NASDAQ:SNPS) traded down 0.35% during mid-day trading on Thursday, hitting $38.915. The stock had a trading volume of 117,234 shares. Synopsys has a 52-week low of $34.55 and a 52-week high of $41.62. The stock’s 50-day moving average is $37.70 and its 200-day moving average is $38.8. The company has a market cap of $6.020 billion and a price-to-earnings ratio of 25.67.

Synopsys (NASDAQ:SNPS) last released its earnings data on Wednesday, May 21st. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.05. The company had revenue of $517.70 million for the quarter, compared to the consensus estimate of $512.15 million. During the same quarter in the previous year, the company posted $0.66 earnings per share. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. Analysts expect that Synopsys will post $2.48 EPS for the current fiscal year.

A number of analysts have recently weighed in on SNPS shares. Analysts at Zacks reiterated a “neutral” rating on shares of Synopsys in a research note on Friday, May 23rd. They now have a $41.00 price target on the stock. Separately, analysts at DA Davidson cut their price target on shares of Synopsys from $47.00 to $46.00 in a research note on Thursday, May 22nd. They now have a “buy” rating on the stock. Finally, analysts at Summit Research upgraded shares of Synopsys from a “hold” rating to a “buy” rating in a research note on Tuesday, May 20th. They now have a $47.00 price target on the stock, up previously from $44.00. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $45.50.

Synopsys, Inc is engaged in providing technology solutions used to develop electronics and electronic systems.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

WellCare Health Plans Upgraded to “Neutral” by Sterne Agee
WellCare Health Plans Upgraded to “Neutral” by Sterne Agee
Research Analysts’ Weekly Ratings Changes for LifePoint Hospitals
Research Analysts’ Weekly Ratings Changes for LifePoint Hospitals
Macy's Receives Average Recommendation of “Buy” from Analysts
Macy's Receives Average Recommendation of “Buy” from Analysts
Zimmer Holdings Stock Rating Reaffirmed by Citigroup Inc.
Zimmer Holdings Stock Rating Reaffirmed by Citigroup Inc.
Zacks Upgrades RTI Surgical to Outperform
Zacks Upgrades RTI Surgical to Outperform
Analysts’ Price Target Changes for July, 29th
Analysts’ Price Target Changes for July, 29th


Leave a Reply

 
© 2006-2014 Mideast Time.